Business
Generic Drug Prices to Rise Due to Tariffs
The CEO of a leading Indian pharma company, Dr Reddy's, warned that Trump’s proposed tariffs on generic drugs will make them more expensive for U.S. patients. The warning highlights potential economic impacts on the healthcare sector.
Coverage timeline — 1 article
CNBC
CEO of Indian pharma company Dr Reddy's has warned that Trump's proposed tariffs on generic drugs will make them more expensive for patients.
2026-07-24 02:24 UTC